HeartBeam (NASDAQ: BEAT) , a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at ...
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12 ...
SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company with a current market capitalization of ...
Funding is part of the Company’s strategic plan focusing on key growth milestones and preparation for U.S. commercialization ...